The price Americans pay for the Inflation Reduction Act (IRA) “pill penalty” and disincentives for follow-on research is a reduction in new cancer treatments, […]
Cancer drug study puts numbers to the cost of IRA’s pill penalty Read More »
Changes brought on by the Inflation Reduction Act (IRA) often increase patient costs and reduce access, while also harming the innovation that brings new
PACE panel notes challenges IRA poses for patients Read More »
The law guiding U.S. drug approval was created to meet the demands of patient advocates, and the patient community still shapes the process. Stakeholders
PACE panel lays out patient input possibilities in PDUFA VIII Read More »
BIO praised a Food and Drug Administration (FDA) initiative targeting more tailored, patient-centered, and predictable development of rare disease drugs, while recommending ways to
BIO supports FDA’s new Fit-for-Purpose Rare Disease Framework Initiative Read More »
The latest portrait of America’s biotech industry describes a growing economic force responsible for $3.19 trillion in total U.S. economic output and employment of
2026 report on biotech’s economic impact portrays a vast ecosystem Read More »
Breakthrough therapies can change the lives of patients who previously had few or no treatments for their conditions, but only if the patients can
PACE panels tackle challenges to access and barriers to coverage Read More »
BIO voices concerns in statement for hearing about potential rule change. Reducing the number of vaccines required for school children risks the spread of
Floridians and health advocates rally to oppose school, daycare vaccine changes Read More »
Continuing confusion about compliance is exacerbating the harms that new pharmaceutical tariffs cause the biotech industry, especially small innovative firms, experts say. Tariffs of
Tariffs’ drag on innovation compounded by lack of guidance, experts say Read More »
Research Triangle Park resurgent with billions in investment in biotechnology manufacturing. With a famous biotech cluster in Research Triangle Park (RTP) established almost 70
BIO on the American Road visits pioneering NC biotech hub Read More »
The BIO 2026 Start-up Stadium winner targets a rare disease. As Herb Sarnoff sits in the hospital, waiting for a pain specialist to see
iNFixion seeks NF1 treatment by enhancing what the body is doing right Read More »
